Bernie Sanders Takes on US Drug Prices with Potential Subpoenas for J&J and Merck
XTalks
JANUARY 24, 2024
The companies are challenging the program, saying it grants the government unjust negotiation powers over US drug pricing, which they say could cause a dent in profits leading to cuts in research and development. ” If authorized, Sanders said these would be the first subpoenas issued by the HELP Committee since 1981.
Let's personalize your content